Moderna Just Received Positive Feedback from the FDA Over This

Moderna announced this week that it has received “positive feedback” from the Food & Drug Administration on its proposal to increase the number of COVID-19 vaccine doses that are in each of its vials.

The Centers for Disease Control and Prevention has noted that one vial of the company’s two-shot vaccinr contains ten doses, which is enough for five people.

It was last month that a CNBC report had said that Moderna requested permission from the FDA to fill its COVID-19 vaccine vials with up to five additional doses.

In prepared testimony submitted ahead of a House hearing on Tuesday, Moderna President Stephen Hoge had revealed that the FDA had given the company “positive feedback on our proposal, and we are pursuing a plan that may allow up to 15 doses to be drawn from each vial.”

“This will allow us to produce and deliver more doses more quickly,” Hoge said to the House Energy and Commerce Committee Subcommittee on Oversight and Investigations.

“We will continue to collaborate with our manufacturing partners and the federal government to increase the efficiency of our production process without compromising quality or safety,” he added.

It was earlier this month that President Joe Biden had said his administration secured deals with Pfizer and Moderna for another 200 million doses of Covid-19 vaccine. This brings the U.S. total to 600 million.

The total would be enough to inoculate 300 million people, which the Biden administration expects all to be given by the end of July.

It was also earlier this month that Moderna announced that the European Commission purchased an additional 150 million doses of its COVID-19 vaccine, which are scheduled to be delivered in the third and fourth quarter of 2021. This brings its confirmed order commitment to 310 million doses for delivery in 2021.

Under the terms of the agreement, the European Commission has the option to purchase an additional 150 million doses to be delivered in 2022.

“We appreciate the European Commission’s confidence in Moderna and our mRNA platform. Today’s purchase of an additional 150 million doses brings their total order of our COVID-19 vaccine to 310 million for delivery in 2021,” said Stéphane Bancel, Chief Executive Officer of Moderna.

“The European Commission is in discussions with us on how to prepare for 2022, including addressing potential variants, and the Commission has an option for an additional 150 million doses for delivery in 2022. Moderna is committed to working relentlessly to bring to market vaccine boosts with the relevant variants to address this global pandemic.”

Disclaimer: We have no position in any of the companies mentioned and have not been compensated for this article.